Previous Close | 4.5200 |
Open | 4.4900 |
Bid | 4.5000 x 100 |
Ask | 5.7000 x 100 |
Day's Range | 4.3800 - 4.6773 |
52 Week Range | 3.0300 - 10.3000 |
Volume | |
Avg. Volume | 92,711 |
Market Cap | 155.675M |
Beta (5Y Monthly) | 1.33 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.0200 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.57 |
Q4 2023 Achieve Life Sciences Inc Earnings Call
ACHV Aligns with EPS Projections, Focuses on Cytisinicline Development
Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial results and provided an update on the cytisinicline development program. Recent Highl